Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.

Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.

OBJECTIVE: To assess the tolerability and efficacy of amodiaquine (AQ)+sulphadoxine-pyrimethamine (SP), the first-line malaria treatment in Rwanda. METHOD: Randomized, double-blind trial in 2003 in Kigali town. A total of 351 adult patients with uncomplicated Plasmodium falciparum malaria were rand...

Full description

Bibliographic Details
Main Authors:	Fanello, C, Karema, C, van Doren, W, Rwagacondo, C, D'Alessandro, U
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
by: Karema, C, et al.
Published: (2006)

The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
by: Amin, A, et al.
Published: (2005)

Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
by: Hamid, MMA, et al.
Published: (2018)

A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
by: Fanello, C, et al.
Published: (2007)

The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
by: East African Network for Monitoring Antimalarial Treatment (EANMAT)
Published: (2003)

A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria.
by: Fanello, C, et al.
Published: (2008)

Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
by: Karema, C, et al.
Published: (2010)

The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
by: Ogutu, B, et al.
Published: (2005)

The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.
by: Winstanley, P, et al.
Published: (1992)

Oral lichenoid reactions during antimalarial prophylaxis with sulphadoxine-pyrimethamine combination
by: Zain, R.B.
Published: (1989)

Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.
by: Maguire, J, et al.
Published: (2002)

A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos.
by: Mayxay, M, et al.
Published: (2003)

Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
by: Karbwang, J, et al.
Published: (1987)

Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger
by: Grais, R, et al.
Published: (2018)

The data presented by Jelinek et al. (1997) should not be taken as evidence against an association between resistance to sulphadoxine-pyrimethamine (S/P) and mutations in the dihydrofolate reductase gene of Plasmodium falciparum.
by: White, N
Published: (1998)

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
by: Schramm, B, et al.
Published: (2013)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
by: Peto, TJ, et al.
Published: (2022)

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
by: Shulman, C, et al.
Published: (1999)

A PHASE 4 RANDOMISED STUDY TO ASSESS THE TOLERABILITY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN LIBERIA
by: Schramm, B, et al.
Published: (2010)

Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa
by: Zwang, J, et al.
Published: (2017)

Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya
by: Mutanyi, JA, et al.
Published: (2021)

Correlation of amodiaquine sensitivity to chloroquine and quinine against Plasmodium falciparum in vitro
by: Perpustakaan UGM, i-lib
Published: (1998)

EFFICACY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN NIMBA COUNTY, LIBERIA
by: Schramm, B, et al.
Published: (2010)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
by: Ravenhall, M, et al.
Published: (2016)

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
by: Smithuis, F, et al.
Published: (1997)

Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
by: Peto, T, et al.
Published: (1985)

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru
by: Grande, T, et al.
Published: (2007)

Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.
by: Mcgready, R
Published: (2010)

Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria.
by: Looareesuwan, S, et al.
Published: (1985)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
by: Chiodini, P, et al.
Published: (1995)

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.
by: Certain, L, et al.
Published: (2008)

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
by: Sulo, J, et al.
Published: (2002)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
by: Lederman, E, et al.
Published: (2006)

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data
by: Adjuik, M, et al.
Published: (2015)

Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial.
by: Espié, E, et al.
Published: (2012)

Fever in uncomplicated Plasmodium falciparum infection: effects of quinine and paracetamol.
by: Krishna, S, et al.
Published: (1995)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
by: Ruizendaal, E, et al.
Published: (2017)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
by: Zongo, I, et al.
Published: (2015)

Effects of intermittent preventive treatment with two doses of sulphadoxine-pyrimethamine in malaria infection and its associated adverse pregnancy outcomes: a systematic review
by: Balami, Ahmed Dahiru, et al.
Published: (2018)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
by: Valea, I, et al.
Published: (2014)